SUV-measurements and patient-specific corrections thereof in pediatric Hodgkin-lymphoma: Is there a benefit for PPV in early response assessment by FDG-PET
Pediatric Blood & Cancer, 05/04/2012
Furth C et al. – At early response assessment by FDG–PET, patient–specific correction of deltaSUVmax by BSA improves positive predictive value (PPV) without impairment of excellent NPV in pHL. However, it is not statistically superior to simple SUVmax–analyses. Larger cohorts are needed to investigate this observation.